Skip to main content
Fig. 7 | Cell & Bioscience

Fig. 7

From: Tumor-derived interleukin-1 receptor antagonist exhibits immunosuppressive functions and promotes pancreatic cancer

Fig. 7

A schematic model of the tumor-promoting functions of IL-1Ra in PDA. Tumor cell-derived IL-1Ra creates an immunosuppressive tumor microenvironment (TME, blue) that inhibits immunogenic anti-cancer functions. The IL-1Ra inhibits T cells and APCs activities, and maintains immunosuppressive mononuclear cells (CD11b+Ly6G−). Interruption of IL-1Ra disrupts the immunosuppression, preventing the localization of CD11b+Ly6G− cells and inducing inflammatory anti-tumor immune responses in the TME (red). Thus, APCs can successfully coordinate the signals from CD4+ T helper and lead to anti-tumor activation of CTLs. Th: T helper cells. CTLs: CD8+ cytotoxic T-cell lymphocytes. APCs: antigen-presenting cells. KO: gene knockout

Back to article page